|
|
Volumn 148, Issue 2, 2008, Pages 168-
|
|
In response
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CORTICOSTEROID;
INFLIXIMAB;
INTERLEUKIN 6;
INTERLEUKIN 6 ANTIBODY;
STEROID;
TUMOR NECROSIS FACTOR ANTIBODY;
BIOPSY;
CLINICAL PRACTICE;
COST BENEFIT ANALYSIS;
DRUG EFFECT;
GIANT CELL ARTERITIS;
HUMAN;
LETTER;
LOW DRUG DOSE;
PATIENT CARE;
PRIORITY JOURNAL;
RECURRENT DISEASE;
RHEUMATIC POLYMYALGIA;
STATISTICAL SIGNIFICANCE;
TREATMENT RESPONSE;
VISUAL IMPAIRMENT;
|
|
EID: 43249127051
PISSN: 00034819
EISSN: None
Source Type: Journal
DOI: 10.7326/0003-4819-148-2-200801150-00019 Document Type: Letter |
|
Times cited : (2)
|
|
References (0)
|
